These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 30612698)

  • 21. New frontiers of therapy in hemato-oncology.
    Mukherjee N
    J Assoc Physicians India; 2002 Jul; 50():950-61. PubMed ID: 12126354
    [No Abstract]   [Full Text] [Related]  

  • 22. [Targeted therapy in the treatment of solid tumors and in hematology-oncology. Advances and disappointments].
    Jochims C; Mazitschek U; Jäger D; Goldschmidt H
    Internist (Berl); 2006 Jun; 47(6):633-41. PubMed ID: 16767478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Advances in medical oncology].
    Shi YK
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun; 28(3):305-10. PubMed ID: 16900620
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeted and tailored therapy in hemato-oncology: vision for the 21st century.
    Shpilberg O; Ben-Bassat I; Raanani P
    Isr Med Assoc J; 2006 Dec; 8(12):843-4. PubMed ID: 17214100
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Customer pyramid framework for CAR T-cell therapies in immuno-oncology.
    Malik NN; Durdy MB
    Drug Discov Today; 2016 Oct; 21(10):1563-1565. PubMed ID: 27640934
    [No Abstract]   [Full Text] [Related]  

  • 26. Immuno-Oncology in China.
    Lu S; Chabner BA
    Oncologist; 2019 Feb; 24(Suppl 1):S1-S2. PubMed ID: 30819825
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advances in pediatric hematology/oncology.
    Raetz E
    Curr Opin Pediatr; 2017 Feb; 29(1):1-2. PubMed ID: 27870690
    [No Abstract]   [Full Text] [Related]  

  • 28. New advances and future directions in pediatric hematology/oncology.
    Raetz E
    Curr Opin Pediatr; 2016 Feb; 28(1):1-2. PubMed ID: 26709679
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical advances in pediatric hematology & oncology: cooperative group research.
    Reaman GH
    Clin Adv Hematol Oncol; 2005 Feb; 3(2):133-5. PubMed ID: 16166982
    [No Abstract]   [Full Text] [Related]  

  • 30. [Major therapeutic advances and new perspectives in onco-hematology].
    Bay JO; Guièze R; Ravinet A; Lemal R; Xhaard A; Bailly S; Moluçon-Chabrot C; Hermet E; Biau J; Verrelle P; Peffault de Latour R; Tournilhac O
    Bull Cancer; 2013 Jun; 100(6):587-99. PubMed ID: 23735575
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prospect for chimeric antigen receptor-engineered T cell immunotherapy for solid tumors].
    Zhou SY; Shi YK
    Zhonghua Zhong Liu Za Zhi; 2018 Jul; 40(7):490-492. PubMed ID: 30060355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trends in the global immuno-oncology landscape.
    Tang J; Pearce L; O'Donnell-Tormey J; Hubbard-Lucey VM
    Nat Rev Drug Discov; 2018 Nov; 17(11):783-784. PubMed ID: 30337722
    [No Abstract]   [Full Text] [Related]  

  • 33. [A 2022 inventory in oncology news].
    Bay JO; Bouleuc C; Caux C; Delom F; Firmin N; Gandemer V; L'Allemain G; Magné N; Orbach D; Robert J; Rodrigues M; Sabatier R; Thiery-Vuillemin A; Wislez M;
    Bull Cancer; 2023 Jan; 110(1):19-31. PubMed ID: 36529541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. From New directions in immuno-oncology.
    Romero D
    Nat Rev Clin Oncol; 2019 Nov; 16(11):660. PubMed ID: 31541198
    [No Abstract]   [Full Text] [Related]  

  • 35. [New immunological concepts in oncology].
    Versicherungsmedizin; 2013 Sep; 65(3):156-7. PubMed ID: 24137899
    [No Abstract]   [Full Text] [Related]  

  • 36. Highlights of the First International "Immunotherapy in Pediatric Oncology: Progress and Challenges" Meeting.
    Capitini CM; Cooper LJ; Egeler RM; Handgretinger R; Locatelli F; Sondel PM; Mackall CL
    J Pediatr Hematol Oncol; 2009 Apr; 31(4):227-44. PubMed ID: 19346873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Not Available].
    Alcazer V; Delenda C; Poirot L; Depil S
    Bull Cancer; 2018 Dec; 105 Suppl 2():S178-S187. PubMed ID: 30686356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pediatric oncology: current views and outcomes.
    Reaman GH
    Pediatr Clin North Am; 2002 Dec; 49(6):1305-18, vii. PubMed ID: 12580367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of chimeric antigen receptor T-cell (CAR-T) therapy in patients with haematological and solid malignancies: protocol for a systematic review and meta-analysis.
    Grigor EJM; Fergusson DA; Haggar F; Kekre N; Atkins H; Shorr R; Holt RA; Hutton B; Ramsay T; Seftel M; Jonker D; Daugaard M; Thavorn K; Presseau J; Lalu MM
    BMJ Open; 2017 Dec; 7(12):e019321. PubMed ID: 29288188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monoclonal antibodies in clinical hematology and oncology.
    Nagorsen D; Thiel E
    Curr Opin Investig Drugs; 2007 Dec; 8(12):996-1001. PubMed ID: 18058570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.